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INTRODUCTION: Plantar hyperhidrosis is present in 50% of patients with hyperhidrosis. Thoracic sympathectomy is an important 
tool for the treatment of this condition, which is successful in about 60% of patients. For the remaining patients, lumbar sympath-
ectomy is the procedure of choice. As new minimally invasive techniques have been developed, a significant demand for this type 
of access has led to its adaptation to the lumbar sympathectomy. The objective of this study was to evaluate the effectiveness of 
endoscopic retroperitoneal lumbar sympathectomy in controlling plantar hyperhidrosis and its effects on compensatory sweat.
MATERIALS AND METHODS: Thirty female patients with persistent plantar hyperhidrosis after thoracic sympathectomy were 
enrolled. They were randomly assigned to laparoscopic retroperitoneal lumbar sympathectomy (Group A) or no surgical interven-
tion (Group B - control) groups. Quality-of-life modifications were assessed by specific questionnaires before and after surgery. In 
the same manner, direct sweat measurements were also performed pre- and post-intervention by evaluating trans-epidermal water 
loss. Despite the lack of intervention, the control group was evaluated at similar timepoints.
RESULTS: In Group A, no major complications occurred in the peri-operative period. During the immediate post-operative period, 
three patients (20%) experienced prolonged pain (more than ten days). Eight patients suffered from worsened compensatory sweat-
ing (53.3%). In Group A, after lumbar sympathectomy, the quality of life significantly improved (p<0.05, intra-group comparison) 
beyond that of the control group (p<0.05, inter-group comparison). Also, lumbar sympathectomy resulted in significantly lower 
values of foot sweat (pre- vs. post-operative periods, p<0.05; Group A vs. Group B, p<0.05). These patients also developed higher 
values of sweat measurements on specific points of their dorsal and abdominal regions after the procedure (p<0.05).
CONCLUSIONS: The endoscopic retroperitoneal lumbar sympathectomy diminishes plantar sweat and improves the quality of 
life of women with plantar hyperhidrosis. However, about half of the patients develop increased compensatory hyperhidrosis in 
other areas of the body.
KEYWORDS: Retroperitoneal space. Sympathectomy. Quality of life. Laparoscopy. Women.
INTRODUCTION
The lumbar sympathectomy was first described by Julio 
Diez,1 of Buenos Aires, Argentina, in 1924 and subsequently 
by Royle2 in Australia and Adson3 in the United States. It 
was initially utilized for the treatment of ischemic and pain-
ful disorders of the lower limbs. This treatment, which was 
popular among vascular surgeons, remained unchanged for 
several decades. Its use slowly decreased after 1960, when 
arterial reconstruction techniques were introduced. It is still 
useful for some patients with vascular diseases; however, it is 
particularly useful in the treatment of plantar hyperhidrosis 
(PHH).4
Primary hyperhidrosis (HH) is the most frequent indica-
tion for sympathectomies, both lumbar and thoracic.4 This 
disease affects about 1% of the population and is character-
ized by excessive sweating in specific regions of the body 190
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such as the hands, face, scalp, axilla and feet. The endo-
scopic thoracic sympathectomy (ETS) is indicated for the 
treatment of palmar, axillary and craniofacial hyperhidrosis. 
The results of plantar excessive perspiration, however, are 
less expressive (improved in up to 58% of cases).5 Many 
patients with PHH who have undergone ETS still continue to 
experience excessive sweating of the feet after surgery. 
The endoscopic retroperitoneal lumbar sympathectomy 
(ERLS) is efficient in the treatment of PHH isolated from 
or associated with other affected areas that persisted after 
ETS.6-7 It is believed, however, that there could be a wors-
ening of compensatory sweating (CS), when adding the 
effects of ETS to the lumbar regions of the same patient.8-10 
It is highly probable that suppression of one more segment 
of the sympathetic chain could actually increase CS. This 
is one of the principal doubts concerning lumbar sympath-
ectomy but, despite this, has not been well-characterized in 
the literature. 
The objective of this study was to evaluate whether 
endoscopic retroperitoneal lumbar sympathectomy is ef-
fective in controlling plantar hyperhidrosis and whether it 
increases the compensatory sweat generated after thoracic 
sympathectomy. To accomplish this, we utilized a quality-of-
life questionnaire and evaluated for sudoresis by measuring 
transepidermic water loss. 
PATIENTS AND METHODS 
The sample consisted of female patients who presented 
with PHH at the time of surgery and received ETS at our 
hospital. Because ETS can improve PHH, we exclusively 
selected those patients for whom this surgery had not yet 
caused the desired effect. ERLS was offered as a form of 
treatment. The volunteers were then evaluated for inclusion 
in the study. 
Thirty-one females aged 17 to 44 years (mean = 23.3 
years) were included. Before ETS, 14 of those patients pre-
sented with palmar and plantar HH, one with axillary and 
plantar, 15 with axillary, palmar, and plantar, and one with 
craniofacial and plantar.
Of the 31 patients initially selected, only one declined to 
participate. The remaining patients met the inclusion criteria 
and signed an informed consent after clarification of treat-
ment characteristics, necessary evaluations, and participa-
tion in scientific research. In addition, all were given initial 
data regarding results from the lumbar sympathectomy in 
controlling PHH.
After the initial evaluation with the quality-of-life (QOL) 
questionnaire and sweat measurements, patients were 
randomized into two groups: Group A (test) and Group B 
(control). Each patient was asked to randomly select a piece 
of paper from a bag in order to determine placement with a 
specific group (Figure 1).
Quality-of-life questionnaire.
The QOL questionnaire referred to the compromis-
ing effects of HH on the patients’ daily routine, in social, 
professional, and emotional aspects and under specific 
circumstances. 
The form was developed to evaluate the results of ETS5. 
It contained 21 questions divided into five categories, with 
five levels of responses. A score of 21 represented all re-
sponses at level 1, the rating of “excellent” by the patient. 
105 represented all responses at level 5, or “poor”. This rat-
ing system allows for the evaluation of quality of life before 
and after ETS and ERLS, as well as facilitates the under-
standing of the impact of PHH on the patients’ routine. 
Sweat assessment
Sudorometry was accomplished at a specific laboratory, 
where patients remained for at least 30 minutes prior to 
measurement, allowing for thermal and psychological ac-
climatization.
The relative humidity of the air was maintained between 
10% and 60%; the temperature was maintained between 20 
0C and 25 0C. Neither thermal nor emotional or intellectual 
inducers of HH were utilized. 
The equipment chosen to measure HH was the Vapom-
eter®11. It is capable of measuring transepidermic water loss 
(TEWL). The evaporation rate is a measure of flow, calcu-
lated by the increase in relative humidity inside the measur-
ing chamber of the equipment. After chamber contact with 
the skin being examined, the evaporation rate is measured 
and expressed in grams (g) per square meter (m2) per hour 
Figure 1 - Chart of activities191
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(h). The rate varies from 0 to 300g/m2/h. The examiners who 
performed the measurements had been trained in the correct 
utilization of the equipment. 
The skin regions were uncovered at least five minutes 
prior to measurement to facilitate natural evaporation. The 
measurement was taken in a standardized sequence: the 
plantar surface of the feet, supra and infra-umbilical regions, 
palmar surface of the hands, and the dorsal region superior 
and inferior to the projection of the umbilical scar (Figures 
2 and 3).
Surgery
All 15 bilateral ERLSs were performed by the same sur-
geon with the same technical sequence from October 2005 
through November 2006.
Patients underwent general anesthesia with endotracheal 
intubation and were placed in a dorsal decubitus position, 
slightly lateralized with a cushion under the lumbar region. 
Retroperitoneal access was always obtained using an intra-
peritoneal view as a guide to the retroperitoneal placement 
of the first trocar halfway between the iliac crest and the 
inferior costal facet of each side, at the median axillary line. 
Once the extraperitoneal space was established, the other 
trocars were placed equidistant to the first in a semi-lunar 
distribution. 
The first landmark identified was the psoas major muscle. 
In a medial direction, the genitofemoral nerve was identified 
above the psoas tendon. The ureter was then located and 
isolated in the direction of the peritoneum. Following this, 
the lumbar sympathetic trunk was identified medially to the 
muscle where it is covered by a capsule formed by the psoas 
muscle insertion at the lumbar spine (Figure 4). 
Once the capsule was open, the trunk and its ganglia 
were revealed. After correct identification, we proceeded 
with careful resection of the sympathetic ganglia, LG2 and 
LG3 (second and third lumbar ganglia). The length of the 
removed chain was standardized to 4 cm. 
After release from the hospital, the patients were re-
evaluated after one week, one month, and six months. Dur-
ing these consultations, they were interviewed and examined, 
in an attempt to identify their impression of the surgery, its 
results and the development of any side effects. Perspiration 
and evaluation of the quality of life were re-assessed six 
months after the lumbar sympathectomy.
Statistical analysis
After verification of their normal distribution, the data 
were analyzed using the t-test for paired samples. The level 
of significance was established at 5% (p<0.05).
Statistical calculations were performed using the Statis-
tical Package for Social Sciences program (SPSS, version 
10.0).12
RESULTS
Operatory results 
There were no conversions from the endoscopic to open 
access. In addition, there were no perioperative complica-
tions like lumbar vessel bleeding, lesions of the vena cava, or 
lesions of the ureter or genitofemoral nerve. Hospitalization 
varied from one to three days, with a mean of 2.3 days. 
Figure 2 - Plantar sudorometry and transmission of data by wireless sys-
tem
Figure 3 - Localization of 8 points of measurement (right foot, left foot, 
abdomens; supra and infra-umbilical, right hand, left hand, dorsal; supra 
and infra)
Figure 4 - Paravertebral lumbar sympathetic trunk (white arrow) under the 
vena cava (yellow arrow)192
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In the early post-operative period, some patients expe-
rienced progressively decreasing but prolonged pain for 
more than ten days (3 patients; 20%) or up to three months 
(1 patient). The mean time off of work was 13.5 days; this 
ranged from 5 to 22 days. 
With respect to CS, we observed that six months after 
ERLS, seven (46.6%) patients did not report worsening. One 
patient reported slight improvement in CS development in 
the legs after ETS. The remaining (53.33%) patients, how-
ever, reported an increase in CS. This worsening, classified 
on a scale of 1 to 10, presented values that varied from 3 to 
8 (mean= 5.87). 
The aesthetic result, evaluated six months after surgery, 
was considered good in eight (53.3%) of the patients, con-
sidered average for five (33.3%) and considered poor for two 
(13.3%) patients.
Two patients (13.33%) reported sexual alterations: in 
one, an increase in libido; in the other, a slight decrease in 
vaginal lubrication, without interference in sex life. 
In two patients (13.33%), there was a temporary recur-
rence of palmar sweating around the second month after 
surgery. 
 No patient expressed regret over having undergone the 
surgery.
Quality of life
The QOL scores were expressed as minimum values, 
maximum values, means, and standard deviations. These are 
presented in Figure 5. We observed the best mean (lowest 
numerical value) in the test group (26.33) after ERLS. This 
was close to the minimum possible value of 21. Patients with 
persistent PHH who underwent ERLS presented values close 
to ideal in the QOL indices related to HH. 
The mean scores of QOL after ERLS in the test groups 
presented a considerable decrease from 48.8 to 26.33. When 
comparing these scores, we observed a statistical difference 
between the pre- and post-ERLS periods (Figure 6). Patients 
with PHH who underwent ERLS commented on improve-
ments in quality of life.
Six months after ERLS, the QOL scores in the test group 
were compared to control group results. A considerable 
difference between the groups (means of 26.33 and 47.6, 
respectively) was observed (Figure 7). After ERLS, patients 
in the test group presented with a greater improvement in 
QOL relative to the control group patients.
Sweat measurement
We observed that values from the sweating assessment of 
the right and left feet in the test group before and after ERLS 
Figure 5 - Quality of life scores.
Figure 6 - Comparison between the QOL scores of the test group before 
and after intervention (ERLS). Test group in red (p<0.05)
Figure 7 - Comparison between the QOL scores of the control group in the 
interview of 6 months and the test group after the VRLS. Control group in 
blue and test group in red (p< 0.05)193
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were different, with a decrease in the pre-operative mean 
from 64 to 22.6g/m2/h and a decrease in standard deviation 
from 42.42 to 8.88, which made the group much more ho-
mogenous. The comparison between the two measures dem-
onstrates a reduction in sudoresis after surgery. The values 
were significantly different (Figure 8). Patients with PHH 
who underwent ERLS experienced less sweating.
To corroborate these results, the foot sweat assessment 
values for the test group after ERLS were compared to the 
corresponding results in the control group after six months. 
The means, 22.6 and 45.12 g/m2/h, respectively, were signifi-
cantly different (p<0.05) (Figure 9). Patients who underwent 
ERLS experienced less sweating of the feet than did the 
control group.
With respect to compensatory sweating, measurements of 
dorsal and abdominal sudoresis allowed for the identification 
of some changes. With respect to the measurements of dorsal 
sweating in the superior (supra) position, the values of the 
test group after ERLS were greater than the corresponding 
values of the control group. A significant difference was 
observed between the means. Compared to patients in the 
control group, patients who underwent ERLS presented with 
an increase in compensatory sweating in the superior dorsal 
position (Figure 10). 
The same increase occurred for values of abdominal 
sweating in the infra-umbilical position. The test group had 
comparatively greater values than the control group. The dif-
ference between the means was also statistically significant. 
As compared to patients in the control group, patients who 
underwent ERLS presented with an increase in compensa-
tory sweating in the infra-umbilical position (Figure 11). 
DISCUSSION
The surgical endoscopic sympathectomy performed on 
the thorax is superior to any other treatment modality for 
HH.5,13,14-17 ERLS appears to be a more adequate method of 
obtaining the anhidrotic effect of the feet, as it is minimally 
invasive and allows for visualization and precise identifica-
tion of the sympathetic chain. Resection can be safely per-
formed without the inconvenience of open surgery.
Measurement methods
When one attempts to measure sympathectomy results, it 
Figure 8 - Comparison between the values of sweat assessment of the feet 
before and after the VRLS. The circles represent values atypical measures. 
Test group in red (p<0.05)
Figure 9 - Comparison between the values of sweat assessment of the feet 
of the control group six months after VRLS. The circles represent atypical 
measures. Control group in blue and test group in red (p<0.05)
Figure 10 - Comparison of values of assessment of dorsal supra sweating be-
tween the control groups six months after VRLS. The circles represent atypi-
cal value measurements. Control group in blue and test in red (p<0.05)194
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is fundamental to use direct sweating assessment methods. A 
measure of transepidermic water loss (TEWL) was utilized 
in this study. This measurement has been used to test new 
products in the cosmetic industry and has been recently 
tested for sweat assessment.11,18,19 This measure of evapora-
tion flow from the skin can be perfectly interpreted as the 
sudation rate.8,11 
This method was practical and capable of identifying 
differences in the sudation rate provoked by ERLS in this 
study. However, other studies are necessary to investigate the 
limitations of the TEWL measurement for the evaluation of 
sympathectomy results. 
Endoscopic Surgery
Endoscopic surgery enabled our patients to return home 
quickly and resume normal activities rapidly. Less surgi-
cal stress and more-controlled tissue lesions enabled the 
patient to move about and also reduced complications. The 
concept of endoscopic surgery incorporated for thoracic 
sympathectomy brings about a great technical advance. A 
surgery that was at one time performed using large inci-
sions, causing intense discomfort and high morbidity, has 
become minimally invasive. The innovation of minimal 
invasiveness has rapidly been adapted to surgical manipula-
tion of the sympathetic chain due to its simplicity, rapidity, 
efficacy and less-aggressive nature. Similarly, the choice 
of a surgical method for controlling PHH should be endo-
scopic. ERLS comparisons with open surgery demonstrated 
its clear aesthetic superiority as well as overall functional 
recovery.21,22 
Resection level and pre-operative localization
In this study, we performed a LG2 and LG3 sympathec-
tomy, following the principle that LG2 is situated along the 
lumbar spine, below the inferior renal pole, which should be 
our superior limit of dissection. Once the ganglion was lo-
cated, its resection followed, as well as resection of the next 
ganglion immediately inferior to it. The anatomic location of 
the kidneys was confirmed by the pre-operative ultrasonogra-
phy in all patients. Lumbar sympathectomy is predominantly 
a pre-ganglion surgery when LG4 is left intact because that’s 
where the majority of the synapses of pre- and post-ganglion 
fibers occur.9 We decided to remove only LG2 and LG3. This 
delimits the sympathetic denervation to the territory below 
the knee line. 
Discussion of results 
Fifteen patients in each of the groups does not seem to be 
a large group, but compared to the ERLS series described in 
the literature,22,24-27 this can be considered expressive.
Despite the minimal cuts, the aesthetic outcome was only 
considered good for 53% of patients. This fact demonstrates 
a high degree of aesthetic exigency in this population, mak-
ing conventional surgery for PHH almost unacceptable for 
these young patients. Hyperhidrosis interferes with patient 
self-esteem and vanity, which obliges surgeons to search for 
the best possible cosmetic results in this type of treatment. 
Compensatory sweating
In the present study, CS characterization was performed 
by directed questions, analyses of QOL and sweating as-
sessment. When patients were asked for their impression 
about CS at six months after the operation, the results were 
similar to those of our previous study.28 Of the 15 patients, 
53% reported worsening of CS, mainly on hotter days or 
when performing physical activities. The mean BMI (body 
mass index) of the operated group was low (21.7 kg/m2); the 
group consisted of thin patients. It is known that the greater 
the BMI the worse is CS development.5 The only participant 
with a BMI greater than 25 kg/m2 was the patient who pre-
sented with the worst CS. Considering only the subjective 
impression of patients, we observe that there is an increase 
in CS after ERLS; this could be related to BMI. 
Quality of Life
Analyzing the means and standard deviations of the QOL 
scores in the test group, we observed a considerable drop in 
QOL values after ERLS. The mean decreased from 73.08 
Figure 11 - Comparison of sweat assessment values in the abdominal 
infra-umbilical region between control groups six months the first measure 
and test group 6 months after ERLS. Control group in blue and test group 
in red (p<0.05)195
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points to 26.33 (best possible score: 21). This reflects the 
effectiveness of ERLS in the control of PHH and the incon-
venience that the disease generated in these patients. 
These results are confirmed in the comparison between 
post-ERLS scores of the test and control groups six months 
after the first interview. The mean scores were 26.3 and 47.6, 
respectively, with a significant advantage for the test group. 
The improvement of plantar sweating supplanted even the 
occasional inconvenience caused by the development or 
worsening of CS. For these patients, CS is not as important 
as PHH, even if it might be considered more visible than 
foot sweat. The ability to use an open shoe, to dance, and to 
be free of foot infection should not be underestimated for a 
woman, especially in a hot climate. 
Sweat Measurement
With the aim of objectively proving ERLS effectiveness 
with respect to the control of foot sweating, two comparisons 
were made. In the test group, the amounts of foot sweating 
were compared before and after ERLS. The observed values 
demonstrate that patients presented with significantly lower 
measures of plantar sudoresis after the procedure. A second 
comparison examined plantar sudoresis of the test group 
after ERLS versus the equivalent measures of the control 
group. In this case, we also observed measurements of 
plantar sudoresis of the test group to be significantly lower 
than those of the control group. Therefore, this confirms that 
the patients who underwent ERLS experienced less sweat-
ing of the feet; this alteration is directly assessed by the 
TEWL measurement, as previously observed in other studies 
(Pedevilla et all, 7th International Society of Sympathetic 
Surgery; 2007).
Prior to the present study, some evidence suggested that 
surgery did indeed, provide control in PHH. At that point, 
the evidence for sudoresis control was limited to the degree 
of patient satisfaction after ERLS, as well as the clinical ob-
servation of dry feet skin. Currently, we have more objective 
criteria for this evaluation at our disposal. Combining these 
analyses with improvements in quality of life and results 
reported by the patients, we can confirm the efficiency of the 
ERLS in PHH treatment. 
The development or worsening of CS was reported by 
8 (53.3%) of our patients. Several comparisons were made 
with the intent to confirm this observation. The values for 
sweating in the abdominal and dorsal regions were compared 
between the test and control groups and between the pre- and 
post-ERLS period, grouping the supra- and infra-umbilical 
measurements, as well as measuring them separately. 
Comparing sweat from the supra-umbilical region of the 
test group to the corresponding values of the control group, 
and consecutively for the infra-umbilical, superior dorsal, 
and inferior dorsal regions, we were able to obtain some 
significant information. There was a statistical difference 
between the superior dorsal and infra-umbilical regions. 
Patients of the test group presented with more sweating in 
these regions relative to the control group. These data, in as-
sociation with those obtained in the post-ERLS interview, led 
to the observation that this surgery can provoke an increase 
in CS, for patients who have undergone prior ETS. Further-
more, these data corroborate previous studies.9,10
Future Perspectives
The TEWL utilized in this study demonstrates a practi-
cal, reliable, and easily reproducible method of measuring 
sudoresis. It should be adopted as the method of choice for 
objective measurement of sweating in future studies. On 
the other hand, QOL questionnaires also demonstrate their 
importance in the analysis of diseases such as HH. The 
improvement of quality of life is a target parameter in the 
quality of treatment. New models of questionnaires should 
be developed and validated for each region affected by HH. 
Randomized studies can serve to improve the quality of 
future studies. Similar methodology can be utilized in the 
evaluation of other sympathectomy results. 
ERLS was determined to be safe, rapid and efficient in 
the control of PHH. Its complications are acceptable and 
well-tolerated by patients. We believe that this technique 
should become the treatment of choice for primary or per-
sistent PHH after ETS, due to the tremendous benefit to 
patients. Its development also depends upon strict participa-
tion on the part of the patients, to whom falls the burden 
of observing and reporting all possible and long-term side 
effects.
Finally, data generated by ETS should be incorporated 
logically into the ERLS. Specifically, future studies should 
investigate the use or non-use of electrocautery, resection or 
clipping of the sympathetic chain, and definition of the level 
of the sympathectomy according to the desired anhidrotic 
effects. 
CONCLUSIONS
The endoscopic retroperitoneal sympathectomy in 
women is a safe surgery with very few and very tolerable 
side effects. It decreases plantar sudoresis and improves the 
quality of life of patients with plantar hyperhidrosis. 
On the other hand, this surgery also promotes an increase 
in compensatory sweating in the dorsal and abdominal 
regions of patients, who previously underwent thoracic en-
doscopic sympathectomy. 196
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